KDM6B and acute myeloid leukemia: Targeting KDM6B with GSK-J4 suppresses cell proliferation and colony formation in AML cell lines, as well as tumor development in an AML xenograft mice model by enriching the H3K27me3 repressive mark in HOX genes’ transcription start sites [103].